drugset / Trial / NCT07243379
A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia
Phase 4
Recruiting
495 enrolled
Changchun GeneScience Pharmaceutical Co., Ltd.
Henan Cancer Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a prospective, real-world observational study. The objective is to evaluate the effectiveness and safety of nanocrystalline megestrol acetate in patients with cancer cachexia in real-world settings. Eligible participants were patients diagnosed with cancer cachexia who were scheduled to receive treatment with nanocrystalline megestrol acetate.
Timeline
- Start
- 2025-09-25
- Primary completion
- 2026-12-31
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Megestrol Acetate | Other / unclassified | 625 mg | Oral |
Indications
No indication recorded.